cagrilintide+Semaglutide CS10 10mg*10vials

Smegglutide CS10 10mg x 10 Vials

Product Overview

Smegglutide CS10 is an upgraded mid-range high-purity lyophilized GLP-1 receptor agonist in the Smegglutide CS series. It is a mainstream standard iteration product developed based on the CS5 basic version. CS10 features optimized molecular stability and balanced bioactivity, supporting moderate effective GLP-1 activation research, bridging the gap between low-dose basic experiments and high-intensity advanced research. It is suitable for routine preclinical validation of glucose and lipid metabolism mechanisms, medium-dose gradient screening, routine efficacy modeling, and stable long-term metabolic intervention studies. With its balanced potency and excellent experimental compatibility, it serves as a widely used core research peptide in routine laboratory projects and the construction of standard metabolic models.

Core Research Functions

GLP-1 Receptor Stable Activation and Physiological Incretin Response Mimicry: Supports GLP-1 receptor stable activation research, body physiological incretin response mimicry studies.

Routine Standardized Metabolic Studies and Insulin Sensitivity Moderate Improvement: Supports routine standardized metabolic studies research, including insulin sensitivity moderate improvement, glycemic homeostasis stabilization, appetite effective suppression and satiety maintenance, and lipid metabolism and fat accumulation balanced interventions.

Stronger Biological Activity and More Significant Metabolic Regulatory Effects: Supports stronger biological activity and more significant metabolic regulatory effects research compared to the low-dose CS5 version, producing clear stable experimental phenotypes without overstimulation related studies.

Mild Controllable Efficacy and Low Model Loss Rate High Data Reproducibility: Supports mild controllable efficacy, low model loss rate, and high data reproducibility research compared to the highly potent high-concentration SM series products.

Reliable Standardized Experimental Data for Routine Validation: Supports reliable standardized experimental data provision research for routine validation of insulin resistance, glucose and lipid metabolism disorders, and dietary regulation mechanisms.

Smegglutide CS10 supports GLP-1 receptor stable activation research, body physiological incretin response mimicry studies. This product focuses on routine standardized metabolic studies, including insulin sensitivity moderate improvement, glycemic homeostasis stabilization, appetite effective suppression and satiety maintenance, and lipid metabolism and fat accumulation balanced interventions. Compared to the low-dose CS5 version, CS10 supports stronger biological activity and more significant metabolic regulatory effects research, producing clear stable experimental phenotypes without overstimulation related studies. Unlike the highly potent high-concentration SM series products, CS10 supports mild controllable efficacy, low model loss rate, and high data reproducibility research. It provides reliable standardized experimental data for routine validation of insulin resistance, glucose and lipid metabolism disorders, and dietary regulation mechanisms.

Core Product Advantages

Balanced Upgrade and Iteration of CS10: The molecular structure has been optimized based on the basic version, moderately enhancing target binding activity and stability, achieving a balance between experimental efficacy and safety research.

Standard Mainstream Concentration of 10mg in the CS Series: Addresses low-dose CS5 insufficient efficacy and ultra-high concentration products overstimulation issues related research, suitable for standard gradient experiments and routine batch modeling.

Mature Lyophilization Activity-Locking Process: Utilizing aseptic vacuum lyophilization technology to support peptide bioactivity full preservation research. Each batch undergoes rigorous HPLC high-purity testing and is accompanied by a complete Certificate of Analysis COA, supporting ultra-low impurity content and stable batch consistency research.

Practical Standardized Packaging: Each box contains 10 vials in a single integrated package, meeting the needs of routine laboratory experiments, academic research projects, standardized model batch validation, and wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 10mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis COA.